Literature DB >> 16101518

Neutrophils and eosinophils: clinical implications of their appearance, presence and disappearance in asthma and COPD.

A P Watt1, B C Schock, M Ennis.   

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are common chronic disorders. Traditionally, asthma has been associated with an eosinophilic inflammation and COPD with neutrophilic inflammation. In this review we will highlight the maturation, recruitment, activation, action and apoptosis of these cells. In addition we will focus on the evidence for their presence in disease and suggest potential new therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16101518     DOI: 10.2174/1568010054526313

Source DB:  PubMed          Journal:  Curr Drug Targets Inflamm Allergy        ISSN: 1568-010X


  17 in total

1.  Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties.

Authors:  José Christian Machado Ximenes; Danilo de Oliveira Gonçalves; Rafaelly Maria Pinheiro Siqueira; Kelly Rose Tavares Neves; Gilberto Santos Cerqueira; Alyne Oliveira Correia; Francisco Hélder Cavalcante Félix; Luzia Kalyne Almeida Moreira Leal; Gerly Anne de Castro Brito; Maria da Graça Naffah-Mazzacorati; Glauce Socorro de Barros Viana
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-14       Impact factor: 3.000

2.  Histone deacetylase inhibitors induce apoptosis in human eosinophils and neutrophils.

Authors:  Hannu Kankaanranta; Mirkka Janka-Junttila; Pinja Ilmarinen-Salo; Kazuhiro Ito; Ulla Jalonen; Misako Ito; Ian M Adcock; Eeva Moilanen; Xianzhi Zhang
Journal:  J Inflamm (Lond)       Date:  2010-02-04       Impact factor: 4.981

Review 3.  NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.

Authors:  Becky A Diebold; Susan M E Smith; Yang Li; J David Lambeth
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

Review 4.  Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease.

Authors:  Katharine H Banner; Neil J Press
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

5.  Regulation of arachidonate remodeling enzymes impacts eosinophil survival during allergic asthma.

Authors:  Michael C Seeds; Kristina K Peachman; David L Bowton; Kelly L Sivertson; Floyd H Chilton
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-16       Impact factor: 6.914

6.  Chemokines mediate ethanol-induced exacerbations of murine cockroach allergen asthma.

Authors:  J C Bouchard; D R Beal; J Kim; L J Vaickus; D G Remick
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

7.  Interleukin (IL)-4 induces leukocyte infiltration in vivo by an indirect mechanism.

Authors:  Claude Ratthé; Jamila Ennaciri; David M Garcês Gonçalves; Sonia Chiasson; Denis Girard
Journal:  Mediators Inflamm       Date:  2009-09-10       Impact factor: 4.711

8.  Systemic inflammation in COPD in relation to smoking status.

Authors:  Danielius Serapinas; Andrius Narbekovas; Jonas Juskevicius; Raimundas Sakalauskas
Journal:  Multidiscip Respir Med       Date:  2011-08-31

9.  Inflammatory markers in chronic obstructive pulmonary disease patients with different α1 antitrypsin genotypes.

Authors:  Danielius Serapinas; Brigita Sitkauskiene; Raimundas Sakalauskas
Journal:  Arch Med Sci       Date:  2012-12-19       Impact factor: 3.318

10.  Eosinophilic inflammation in allergic asthma.

Authors:  Samantha S Possa; Edna A Leick; Carla M Prado; Mílton A Martins; Iolanda F L C Tibério
Journal:  Front Pharmacol       Date:  2013-04-17       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.